Which Modality for Which Breast Density?
The review, conducted by researchers at UC Davis and other institutions, also found that supplemental diagnostic screenings for women with dense breasts find additional breast cancers but also greatly increase false positive results. However, the review team found no studies that examined women's long-term health outcomes after supplemental screening beyond diagnosis. The findings are reported in the Annals of Internal Medicine.
The review of 24 studies among 2,067 citations examined the evidence on the consistency of breast density category assignment and on supplemental screening beyond standard mammography for women with dense breasts. Breast density has been categorised through the Breast Imaging Reporting and Data System (BI-RADS). Breasts are defined as: a) mostly fatty, b) scattered density, c) consistent density and d) extremely dense.
See Also: Study: Does Breast Density Increase Breast Cancer Risk?
"The number of states mandating that breast density information be reported to patients is increasing," says first author Joy Melnikow, professor and director of the Center for Healthcare Policy and Research at UC Davis. "But the assignment of breast density is not terribly consistent. The policy may be out in front of the science."
Higher breast density modestly increases a woman's risk of developing breast cancer and decreases the sensitivity and specificity of screening mammograms. Women with dense breasts may be offered supplemental screening with ultrasound or magnetic resonance imaging (MRI). However, the review shows this approach may not be supported by strong scientific evidence.
Prof. Melnikow suggests that long-term, rigorous research is needed to better standardise breast density classification and determine whether supplemental screenings provide actual health benefits for women.
Study on Imaging Modalities for Different Densities
In another study, researchers at New York-Presbyterian/Weill Cornell Medical Center investigated which modalities -- 2D mammography (2D), digital breast tomosynthesis (DBT), whole breast sonography (WBS) -- or combination of modalities are optimal for screening depending on breast density. The restrospective study covered screening mammograms (16,789; sorted by modalities and density) performed at the centre in 2013.
See Also: EUSOBI 2015: Implications of Dense Breasts
Results showed that cancer detection is increased by adding WBS to 2D (P = .02) for the overall study population. Recall rate was lowest with 2D + DBT (10.2%, P < .001) and highest with 2D + DBT + WBS (23.6%, P < .001) for the overall study population as well.
"Our principal findings were that women with dense and nondense breasts benefit from reduced recall rate with the addition of DBT. However, for both groups, this benefit is negated with the addition of WBS, which in this study significantly increased recall rate over 2D alone in the whole group and in nondense breasts," says the NYP/Weill Cornell team. The results are published in the journal Clinical Imaging.
Source: University of California - Davis Health System; Clinical Imaging.
Image credit: University of California Regents, 2016
Starikov A et al. (2015) 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening
. Clinical Imaging. 6 October 2015. DOI: http://dx.doi.org/10.1016/j.clinimag.2015.10.001
Published on : Tue, 12 Jan 2016
The Next Evolution in Ultrasound, designed for high expectations ARIETTA 850 ultrasound platform responds to high expectations to answer the ever increasing demands of medical professionals. ARIETTA 850’s fundamental performance has been refined...
We recognize that the best chance any patient has at getting better is a clinician at their bedside with all the right answers and the confidence to act. SonoSite education and training is the industry standard – no other point-of-care ultrasound manufacturer...
The best patient care is your ultimate goal. To achieve this requires confident diagnosis even with daily increases in patient throughput. Built on the foundation of Mindray’s continuous customer insights into clinical needs and the inheritance from...
The TE7 touch screen ultrasound system is designed to provide superior quality imaging for rapid patient-care decisions. Intuitive gesture controls and efficient focused point-of-care exams minimize the user learning curve, with no need to navigate a...
Based on Mindray's new generation ultrasound platform, mQuadro, M9 has raised the industry standards to an all new level. Advanced signal transmission and reception processors provide highly sensitive and accurate echo detection. Innovative transducer...